Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 52

1.

The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: a meta-analysis of prospective cohort studies.

Yang WS, Va P, Bray F, Gao S, Gao J, Li HL, Xiang YB.

PLoS One. 2011;6(12):e27326. doi: 10.1371/journal.pone.0027326. Epub 2011 Dec 21.

2.

Diabetes mellitus and poorer prognosis in hepatocellular carcinoma: a systematic review and meta-analysis.

Wang YG, Wang P, Wang B, Fu ZJ, Zhao WJ, Yan SL.

PLoS One. 2014 May 15;9(5):e95485. doi: 10.1371/journal.pone.0095485. eCollection 2014. Review.

3.

Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies.

Wang C, Wang X, Gong G, Ben Q, Qiu W, Chen Y, Li G, Wang L.

Int J Cancer. 2012 Apr 1;130(7):1639-48. doi: 10.1002/ijc.26165. Epub 2011 Jul 28. Review.

4.

Prognostic role of diabetes mellitus in hepatocellular carcinoma patients after curative treatments: a meta-analysis.

Wang WM, Xu Y, Yang XR, Wang YH, Sun HX, Fan J.

Hepatobiliary Pancreat Dis Int. 2011 Aug;10(4):346-55. Review.

PMID:
21813381
5.

Diabetes mellitus: a "true" independent risk factor for hepatocellular carcinoma?

Gao C, Yao SK.

Hepatobiliary Pancreat Dis Int. 2009 Oct;8(5):465-73. Review.

6.

Transarterial chemoembolization versus hepatic resection in hepatocellular carcinoma treatment: a meta-analysis.

Tian X, Dai Y, Wang DQ, Zhang L, Sui CG, Meng FD, Jiang SY, Liu YP, Jiang YH.

Drug Des Devel Ther. 2015 Aug 10;9:4431-40. doi: 10.2147/DDDT.S86629. eCollection 2015. Review.

7.

Anti-diabetic medications and the risk of hepatocellular cancer: a systematic review and meta-analysis.

Singh S, Singh PP, Singh AG, Murad MH, Sanchez W.

Am J Gastroenterol. 2013 Jun;108(6):881-91; quiz 892. doi: 10.1038/ajg.2013.5. Epub 2013 Feb 5. Review.

PMID:
23381014
8.

Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis.

Wang P, Kang D, Cao W, Wang Y, Liu Z.

Diabetes Metab Res Rev. 2012 Feb;28(2):109-22. doi: 10.1002/dmrr.1291. Review.

PMID:
21898753
9.

Diabetes mellitus is associated with elevated risk of mortality amongst patients with prostate cancer: a meta-analysis of 11 cohort studies.

Cai H, Xu Z, Xu T, Yu B, Zou Q.

Diabetes Metab Res Rev. 2015 May;31(4):336-43. doi: 10.1002/dmrr.2582. Epub 2014 Sep 14. Review.

PMID:
25066306
10.

Is diabetes mellitus associated with increased incidence and disease-specific mortality in endometrial cancer? A systematic review and meta-analysis of cohort studies.

Liao C, Zhang D, Mungo C, Tompkins DA, Zeidan AM.

Gynecol Oncol. 2014 Oct;135(1):163-71. doi: 10.1016/j.ygyno.2014.07.095. Epub 2014 Jul 27. Review.

11.

Thrombocytopenia and the outcomes of hepatectomy for hepatocellular carcinoma: a meta-analysis.

Zhang Z, Zhang Y, Wang W, Hua Y, Liu L, Shen S, Peng B.

J Surg Res. 2017 Apr;210:99-107. doi: 10.1016/j.jss.2016.11.002. Epub 2016 Nov 11. Review.

PMID:
28457347
12.

Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases: a systematic review and meta-analysis.

Singh S, Fujii LL, Murad MH, Wang Z, Asrani SK, Ehman RL, Kamath PS, Talwalkar JA.

Clin Gastroenterol Hepatol. 2013 Dec;11(12):1573-84.e1-2; quiz e88-9. doi: 10.1016/j.cgh.2013.07.034. Epub 2013 Aug 15. Review.

13.

Systematic review on urine albumin testing for early detection of diabetic complications.

Newman DJ, Mattock MB, Dawnay AB, Kerry S, McGuire A, Yaqoob M, Hitman GA, Hawke C.

Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. Review.

14.

Systematic review and meta-analysis of the association between diabetes mellitus and incidence and mortality in breast and colorectal cancer.

De Bruijn KM, Arends LR, Hansen BE, Leeflang S, Ruiter R, van Eijck CH.

Br J Surg. 2013 Oct;100(11):1421-9. doi: 10.1002/bjs.9229. Review.

PMID:
24037561
15.

Outcomes of hepatectomy for noncirrhotic hepatocellular carcinoma: a systematic review.

Zhou Y, Lei X, Wu L, Wu X, Xu D, Li B.

Surg Oncol. 2014 Dec;23(4):236-42. doi: 10.1016/j.suronc.2014.11.001. Epub 2014 Nov 8. Review.

PMID:
25465529
16.

Diabetes mellitus and colorectal cancer prognosis: a meta-analysis.

Mills KT, Bellows CF, Hoffman AE, Kelly TN, Gagliardi G.

Dis Colon Rectum. 2013 Nov;56(11):1304-19. doi: 10.1097/DCR.0b013e3182a479f9. Review.

17.

Increased intake of vegetables, but not fruit, reduces risk for hepatocellular carcinoma: a meta-analysis.

Yang Y, Zhang D, Feng N, Chen G, Liu J, Chen G, Zhu Y.

Gastroenterology. 2014 Nov;147(5):1031-42. doi: 10.1053/j.gastro.2014.08.005. Epub 2014 Aug 13. Review.

PMID:
25127680
18.

Diabetes mellitus and incidence and mortality of gastric cancer: a meta-analysis.

Tian T, Zhang LQ, Ma XH, Zhou JN, Shen J.

Exp Clin Endocrinol Diabetes. 2012 Apr;120(4):217-23. doi: 10.1055/s-0031-1297969. Epub 2011 Dec 20. Review.

PMID:
22187293
19.

Prognostic Role of Glasgow Prognostic Score in Patients With Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.

Li MX, Bi XY, Li ZY, Huang Z, Han Y, Zhou JG, Zhao JJ, Zhang YF, Zhao H, Cai JQ.

Medicine (Baltimore). 2015 Dec;94(49):e2133. doi: 10.1097/MD.0000000000002133. Review.

20.

Systematic review with meta-analysis: meat consumption and the risk of hepatocellular carcinoma.

Luo J, Yang Y, Liu J, Lu K, Tang Z, Liu P, Liu L, Zhu Y.

Aliment Pharmacol Ther. 2014 May;39(9):913-22. doi: 10.1111/apt.12678. Epub 2014 Mar 3. Review.

Supplemental Content

Support Center